Trademark: 88711511
Word
ADMARE
Status Date
Thursday, January 4, 2024
Filing Date
Monday, December 2, 2019
41 providing educational programs and training services in the field of pharmaceutical research, development, commercialization, leadership and management, namely, conducting classes, courses, seminars, webinars, workshops, conferences, networking events, mentorship programs, and executive coaching; providing educational programs and training services in the field of pharmaceutical research, development, commercialization, leadership and management, namely, conducting classes, courses, seminars, webinars, workshops, conferences, networking events, mentorship programs and executive coaching, all for undergraduate students, post-graduate trainees and life sciences researchers, scientists, and professionals; providing educational programs and training services in leadership and management for senior or executive-level life sciences researchers, scientists, and professionals, namely, conducting classes, courses, seminars, webinars, workshops, conferences, executive coaching, networking events, and mentorship programs; providing educational programs and training services in the field of pharmaceutical research, development and commercialization for post-graduate trainees, namely, conducting classes, courses, seminars, webinars, workshops, conferences, networking events and mentorship programs; providing educational programs and training services in the field of pharmaceutical research, development and commercialization for undergraduate students, namely, conducting classes, courses, seminars, webinars, workshops, conferences, networking events, and mentorship programs
35 providing job and research personnel placements for business internship, post-doctoral research and undergraduate research; providing scientific consulting services in the field of pharmaceutical commercialization; providing business consulting services in the commercialization of products and services in the field of pharmaceuticals, namely, consulting services in sourcing investments and partners, and analyzing and advancing projects; providing business consulting services for life sciences incubator and accelerator services, namely, consulting services in the commercialization of products and services in the field of pharmaceuticals, consulting services in sourcing investments and partners, and analyzing and advancing projects; providing office facilities in the field of pharmaceutical commercialization, namely, office workspace, office furniture, office equipment, information technology equipment, meeting rooms, and conference rooms; providing office facilities for life sciences incubator and accelerator services, namely, office workspace, office furniture, office equipment, information technology equipment meeting rooms, and conference rooms
45 providing consulting services in the commercialization of products and services in the field of pharmaceuticals, namely, consulting services in intellectual property, commercial transactions, corporate structuring, and pharmaceutical regulatory affairs; providing consulting services for life sciences incubator and accelerator services in the commercialization of products and services in the field of pharmaceuticals, namely, consulting services in intellectual property, commercial transactions and corporate structuring
42 providing scientific and medical research information and drug discovery information in the field of pharmaceuticals; providing scientific consulting services in the field of pharmaceutical research and development; providing research, inspection, evaluation, testing and development services in the field of pharmaceutical research, and development; providing laboratory research services relating to pharmaceutical research and development; providing technical support services, namely, troubleshooting in the nature of diagnosing problems with computerized or electronic laboratory equipment and instruments; organizing and conducting meetings, gatherings, conferences and networking events in the field of pharmaceutical research and development; providing scientific and technical advice for life sciences incubator and accelerator services, namely, scientific and technical advice in the field of laboratory equipment and instruments, technical support services, namely, troubleshooting in the nature of diagnosing problems with computerized or electronic laboratory equipment and instruments, and information technology consulting services; providing scientific and medical laboratory services for life sciences incubator and accelerator services; providing laboratory and office facilities in the field of pharmaceutical research and development, namely, office workspace, office furniture, office equipment, information technology equipment, scientific research laboratories, laboratory equipment and instruments, meeting rooms, conference rooms, and laboratory reagents; providing laboratory and office facilities for life sciences incubator and accelerator services, namely, office workspace, office furniture, office equipment, information technology equipment, scientific research laboratories, laboratory equipment and instruments, meeting rooms, conference rooms and laboratory reagents
The mark consists of geometric figures being solid hexagon shapes to form a fanciful diamond with a hexagon next to the left side of the diamond. The word "ADMARE" is situated to the right of the fanciful diamond shape.
Color is not claimed as a feature of the mark.
Jan 4, 2024
Notification Of Letter Of Suspension E-Mailed
Jan 4, 2024
Letter Of Suspension E-Mailed
Jan 4, 2024
Suspension Letter Written
Jan 4, 2024
Assigned To Examiner
Dec 26, 2023
Teas/Email Correspondence Entered
Dec 26, 2023
Correspondence Received In Law Office
Dec 21, 2023
Teas Response To Suspension Inquiry Received
Oct 14, 2023
Notification Of Inquiry As To Suspension E-Mailed
Oct 14, 2023
Inquiry To Suspension E-Mailed
Oct 14, 2023
Suspension Inquiry Written
Oct 5, 2023
Suspension Checked - To Attorney For Action
Feb 28, 2023
Notification Of Letter Of Suspension E-Mailed
Feb 28, 2023
Letter Of Suspension E-Mailed
Feb 28, 2023
Suspension Letter Written
Feb 24, 2023
Teas/Email Correspondence Entered
Feb 24, 2023
Correspondence Received In Law Office
Feb 23, 2023
Assigned To Lie
Feb 13, 2023
Teas Response To Suspension Inquiry Received
Dec 15, 2022
Notification Of Inquiry As To Suspension E-Mailed
Dec 15, 2022
Inquiry To Suspension E-Mailed
Dec 15, 2022
Suspension Inquiry Written
Nov 17, 2022
Suspension Checked - To Attorney For Action
Nov 4, 2022
Teas Change Of Correspondence Received
Nov 4, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Nov 4, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 4, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 24, 2022
Notification Of Letter Of Suspension E-Mailed
Mar 24, 2022
Letter Of Suspension E-Mailed
Mar 24, 2022
Suspension Letter Written
Mar 10, 2022
Teas/Email Correspondence Entered
Mar 10, 2022
Correspondence Received In Law Office
Mar 7, 2022
Teas Response To Suspension Inquiry Received
Sep 13, 2021
Notification Of Inquiry As To Suspension E-Mailed
Sep 13, 2021
Inquiry To Suspension E-Mailed
Sep 13, 2021
Suspension Inquiry Written
Aug 16, 2021
Suspension Checked - To Attorney For Action
Aug 5, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 5, 2021
Teas Change Of Correspondence Received
Aug 5, 2021
Teas Change Of Domestic Representatives Address
Aug 5, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Aug 5, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 5, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 5, 2021
Teas Change Of Owner Address Received
May 19, 2021
Assigned To Examiner
Nov 18, 2020
Notification Of Letter Of Suspension E-Mailed
Nov 18, 2020
Letter Of Suspension E-Mailed
Nov 18, 2020
Suspension Letter Written
Nov 18, 2020
Notification Of Letter Of Suspension E-Mailed
Nov 18, 2020
Letter Of Suspension E-Mailed
Nov 18, 2020
Suspension Letter Written
Oct 20, 2020
Teas/Email Correspondence Entered
Oct 20, 2020
Correspondence Received In Law Office
Oct 19, 2020
Assigned To Lie
Sep 3, 2020
Teas Response To Office Action Received
Mar 4, 2020
Notification Of Non-Final Action E-Mailed
Mar 4, 2020
Non-Final Action E-Mailed
Mar 4, 2020
Non-Final Action Written
Feb 27, 2020
Assigned To Examiner
Dec 7, 2019
Notice Of Design Search Code E-Mailed
Dec 6, 2019
New Application Office Supplied Data Entered
Dec 5, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
